Definition

Urothelial carcinoma, a type of cancer affecting the bladder, urethra, ureter, and parts of the kidney, stems from irregularities in the cells lining the urinary tract's inner wall.

In certain developing nations, urothelial carcinoma stands as the 6th most prevalent tumor. About 90-95% of cases typically manifest in the lower part of the bladder, while the remaining instances affect the upper urinary tract.

Managing urothelial carcinoma involves various approaches, yet its recurrence rate tends to be high, contingent upon factors such as the disease's stage at diagnosis and the administered treatment.

Causes

The cause of urothelial carcinoma is changes in DNA or DNA mutations occurring in the cells lining the inner wall of the urinary tract. Urothelial carcinoma is predominantly associated with bladder cancer.

Given that the inner lining of the urinary tract consists of similar cell types, urothelial carcinoma can affect various parts of this tract. Although the exact cause of these DNA changes remains unknown, certain risk factors can heighten the likelihood of urothelial carcinoma development.

Cells contain DNA, which serves as the blueprint for the cell's functions and survival. Normally, cells undergo a regulated life cycle with specific limits, ensuring they function properly and do not proliferate uncontrollably. However, mutations in the DNA of cells can disrupt this balance, leading to aberrant cell behavior and potentially making them more aggressive.

These alterations, such as accelerated growth, disrupted life cycles, or resistance to apoptosis (normal cell death), can invade surrounding normal tissue by proliferating abnormal cells. Eventually, these cells may form tumors that further encroach upon neighboring tissue and, in advanced stages, spread to other parts of the body (metastasis).

Previously known as transitional cell carcinoma, urothelial carcinoma derives its name from the urothelial cells that line the inner walls of nearly all urinary tract segments. These cells possess flexible properties, enabling them to expand when the bladder is full and contract when empty.

Risk factor

The risk factors for urothelial carcinoma are diverse, with environmental factors playing a significant role in its development. Some of these factors include:

• Smoking: Both active and passive smokers face a heightened risk of urothelial carcinoma due to exposure to carcinogenic substances found in tobacco smoke.
• Family history of bladder cancer
• Consumption of water containing arsenic, a substance commonly used in pesticides and insecticides
• Alcohol consumption
• Previous history of bladder cancer
• Exposure to hazardous chemicals in the workplace: Certain industries, such as rubber, textile, paint, and leather, involve exposure to carcinogenic chemicals that can elevate the risk of urothelial carcinoma among workers.
• History of radiation therapy

Symptoms 

The symptoms of urothelial cancer depend on its location, with the bladder being a common site. Therefore, the symptoms are similar to those of bladder cancer. Some of these symptoms include:

• Hematuria, or blood in the urine. The urine may appear pink, red, or tea-colored. Sometimes, blood in the urine may not be visible to the naked eye and requires microscopic examination for detection
• Back pain typically caused by the growth of tumor tissue obstructing normal urinary flow
• Urinary problems, such as pain during urination, urinary urgency, and increased frequency of urination
• Loss of appetite
• Weight loss
• Fatigue
• Unexplained fever
• Night sweats, especially at night

Diagnosis

Diagnosis of urothelial carcinoma begins with a medical interview about the symptoms, followed by a physical examination and various diagnostic tests. Some of these tests include:

• Urinalysis: This involves collecting urine and examining it in the laboratory to detect blood or other suspicious components.
• CT urography: This examination has a high accuracy rate for making a diagnosis.
• MRI urography: This is performed if CT urography cannot be done.
• Cystoscopy: This involves inserting a small camera and light-equipped tube into the bladder for examination.
• Cytology: Tissue from the bladder is taken and examined under a microscope.
• Diagnostic ureteroscopy: Like cystoscopy, this examines the ureter and kidney, and a biopsy can be performed on suspicious tissue.
• PET Scan: This is performed to look for metastasis or the spread of cancer to other parts of the body.

Doctors assess the stage of urothelial carcinoma from stage 0 to 4 to determine the extent of cancer spread and the appropriate therapy:

• Stage 0: Cancer has not penetrated the inner wall of the bladder or other parts of the urinary tract.
• Stage 1: Cancer has started to penetrate the inner wall but has not reached the muscle layer outside the organ.
• Stage 2: Cancer has spread to the outer muscle layer.
• Stage 3: Cancer has begun to spread to the surrounding bladder or other urinary tract tissue.
• Stage 4: Cancer has spread beyond the bladder and can metastasize to other parts of the body.

Management

The treatment of urothelial carcinoma depends on the stage of cancer at diagnosis. For early stages (stages 1 and 2), where there is no metastasis and the cancer is localized (e.g., in the bladder), the following treatments and management options are available:

• Ureteroscopy: This procedure uses a ureteroscope to remove tumor tissue. However, there is a high risk of recurrence associated with this treatment.
• Percutaneous management: This treatment targets urothelial carcinoma present in kidney tissue.
• Ureteral resection: This treatment involves surgically removing a portion of the ureter containing urothelial carcinoma."

For carcinoma stages 2 and 3, which carry a high risk of metastasis, the following management options are available:

• Open radical nephroureterectomy: This major surgery involves the removal of one kidney and part of the ureter.
• Bladder removal surgery and affected lymph nodes: Surgery may involve removing the bladder and affected lymph nodes.
• Chemotherapy: Chemotherapy may be administered before or after surgical procedures to target cancer cells throughout the body.
• Immunotherapy: If chemotherapy is ineffective, immunotherapy may be considered as an alternative treatment option.
• Radiation therapy after kidney removal surgery

For stage 4 cancer with metastasis to other organs, systemic treatments involving the entire body are necessary. Some options include:

• Radical nephroureterectomy: This surgical procedure involves the complete removal of the affected kidney and ureter.
• Combination chemotherapy: This treatment approach aims to reduce symptoms and improve the quality of life by targeting cancer cells throughout the body.
• Immunotherapy: Immunotherapy may be utilized to eliminate any remaining cancer cells after surgery and to alleviate symptoms.

Complications 

Complications of urothelial carcinoma can persist even after treatment or organ removal. The risk of recurrence and mortality persists, necessitating regular follow-up checks by doctors. In addition to these complications, other possible issues include:

• Hydronephrosis: This occurs when the cancer obstructs the flow of urine from the bladder or ureter, leading to swelling in the affected kidney.
• Urinary tract infections: These infections may occur due to cancer or as a result of treatment interventions.

Prevention 

Prevention involves avoiding risk factors associated with urothelial carcinoma. Some strategies include:

• Not smoking or quitting smoking. Seek support from your doctor if needed.
• Avoiding exposure to harmful chemicals.
• Adopting a healthy lifestyle.
• Ensuring adequate fluid intake to meet the body's needs.

When to see a doctor?    

If you experience any of the symptoms mentioned above, it's crucial to seek medical attention promptly. Additionally, if you have risk factors associated with urothelial carcinoma, consider seeking medical advice and undergoing regular health check-ups to prevent the onset of this disease. Given the high risk of recurrence, regular periodic check-ups are essential for early detection and management.

Looking for more information about other diseases? Click here!